Contact Us

Areas of Interest :

Join the Conversation​

Contact Sengenics Krex Based Precision Medicine Protein Microarray Company | FaceBook
Contact Sengenics Krex Based Precision Medicine Protein Microarray Company Today | LinkedIn
Contact Sengenics Krex Based Precision Medicine Protein Microarray Company Today

Locations

 

USA
1209 Orange Street
Wilmington
Delaware 19801

 

UK
One Silk Street
London EC2Y 8HQ
England

 

Malaysia
M floor, Block A, Plaza Zurich
Damansara Heights
Kuala Lumpur 50490

Contact Us

General enquiries : [email protected]
Tech support : [email protected]
Press : [email protected]
Careers : [email protected]

FEATURED PRODUCTS

High-throughput autoantibody profiling against 1600+ proteins

Quantification of autoantibodies to 200+ clinically relevant CT antigens

Simultaneous screening of 100+
wild-type and mutant p53

Multi-antigen, multi-domain
COVID-19 antibody test

Sengenics - Functional Proteomics | Krex Technology | Protein Microarray Supplier

Sengenics is a Functional Proteomics company that leverages its patented KREX technology to discover autoantibody biomarker signatures for prediction of drug response and severe immune-related adverse events (irAEs). KREX can also be used to identify autoantibody biomarkers to diagnose cancer, autoimmune, neurodegenerative or infectious diseases with higher sensitivity and specificity than conventional diagnostic tests. Some autoantibodies that are identified as diagnostic biomarkers may be protective and have potential in themselves as therapeutic biomolecules.

Copyright 2008 – 2021 Sengenics All rights reserved | Sengenics Corporation LLC. Registered in Delaware, USA no. 5739583 | Sengenics UK Registered in England and Wales no. 12889389

X